The Effect of Routine Antibiotic Use in the Outpatient Treatment of Severely Malnourished Children Without Complications
1 other identifier
interventional
2,412
1 country
1
Brief Summary
This study will be conducted as a randomized, double-blind, placebo-controlled trial to compare routine antibiotic prescription vs. no routine antibiotic prescription in the management of uncomplicated cases of severe acute malnutrition treated in the community in terms of nutritional recovery. The investigators hypothesize that there will be no significant difference in terms of the risk of nutritional recovery among children uncomplicated cases of severe acute malnutrition treated in the community that receive routine antibiotic prescription and those who receive no routine antibiotic prescription.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 26, 2012
CompletedFirst Posted
Study publicly available on registry
June 7, 2012
CompletedStudy Start
First participant enrolled
October 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2014
CompletedMay 21, 2014
May 1, 2014
1.4 years
May 26, 2012
May 20, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of children discharged from nutritional program as recovered
Until discharge from the nutritional program, an expected average of 5 weeks
Secondary Outcomes (1)
Hospitalization or death
3 months following enrollment
Study Arms (2)
Routine antibiotic prescription
ACTIVE COMPARATORRoutine antibiotic prescription with amoxicillin (80 mg/kg/day for 7 days)
No routine antibiotic prescription
PLACEBO COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Age from 6 to 59 months
- MUAC \< 11.5 cm or WHZ \< -3
- Absence of bipedal edema
- Absence of current illness requiring inpatient care
- Eligible for new admission for outpatient nutritional therapy for SAM at 3 CRENAS in Madarounfa operated by FORSANI
- Absence of current clinical illness requiring prescription of specific antibiotic therapy and decision by the study physician to use a specific antimicrobial drug on admission
- Written consent of parent or caregiver
- Residence within Niger
You may not qualify if:
- Age \< 6 months or \> 59 months
- MUAC ≥ 11.5 cm and WHZ ≥ -3
- Presence of bipedal edema
- Presence of current illness requiring inpatient care
- Decision by the study physician to use a specific different antimicrobial drug on admission
- Presence of any congenital abnormality or underlying chronic disease that may affect growth or risk of infection
- Treatment with any antibiotic within 7 days
- Admission to any nutritional program for the treatment of SAM within 3 months
- Known contraindication / hypersensitivity to amoxicillin
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Epicentrelead
- Medecins Sans Frontieres, Netherlandscollaborator
- FORSANIcollaborator
- District Sanitaire de Madarounfa, Région de Maradicollaborator
- Ministere de la Sante Publique du Nigercollaborator
- Bichat Hospitalcollaborator
Study Sites (1)
Centres de Récupération et d'Education Nutritionnelle Ambulatoires de Dan Issa, Madarounfa, and Gabi
Maradi, Niger
Related Publications (7)
Rattigan SM, Grantz KH, Hanson K, Langendorf C, Berthe F, Grais R, Isanaka S. Prescribing practices in the treatment of wasting: secondary analysis from a randomised trial. BMJ Nutr Prev Health. 2024 Feb 26;7(1):103-111. doi: 10.1136/bmjnph-2023-000785. eCollection 2024.
PMID: 38966095DERIVEDSchwartz DJ, Langdon A, Sun X, Langendorf C, Berthe F, Grais RF, Trehan I, Isanaka S, Dantas G. Effect of amoxicillin on the gut microbiome of children with severe acute malnutrition in Madarounfa, Niger: a retrospective metagenomic analysis of a placebo-controlled trial. Lancet Microbe. 2023 Nov;4(11):e931-e942. doi: 10.1016/S2666-5247(23)00213-6. Epub 2023 Oct 19.
PMID: 37866373DERIVEDBliznashka L, Grantz KH, Botton J, Berthe F, Garba S, Hanson KE, Grais RF, Isanaka S. Burden and risk factors for relapse following successful treatment of uncomplicated severe acute malnutrition in young children: Secondary analysis from a randomised trial in Niger. Matern Child Nutr. 2022 Oct;18(4):e13400. doi: 10.1111/mcn.13400. Epub 2022 Jul 21.
PMID: 35866201DERIVEDMadzorera I, Duggan C, Berthe F, Grais RF, Isanaka S. The role of dietary diversity in the response to treatment of uncomplicated severe acute malnutrition among children in Niger: a prospective study. BMC Nutr. 2018 Sep 20;4:35. doi: 10.1186/s40795-018-0242-y. eCollection 2018.
PMID: 32153896DERIVEDMaataoui N, Langendorf C, Berthe F, Bayjanov JR, van Schaik W, Isanaka S, Grais RF, Clermont O, Andremont A, Armand-Lefevre L, Woerther PL. Increased risk of acquisition and transmission of ESBL-producing Enterobacteriaceae in malnourished children exposed to amoxicillin. J Antimicrob Chemother. 2020 Mar 1;75(3):709-717. doi: 10.1093/jac/dkz487.
PMID: 31821452DERIVEDOldenburg CE, Guerin PJ, Berthe F, Grais RF, Isanaka S. Malaria and Nutritional Status Among Children With Severe Acute Malnutrition in Niger: A Prospective Cohort Study. Clin Infect Dis. 2018 Sep 14;67(7):1027-1034. doi: 10.1093/cid/ciy207.
PMID: 29522089DERIVEDIsanaka S, Langendorf C, Berthe F, Gnegne S, Li N, Ousmane N, Harouna S, Hassane H, Schaefer M, Adehossi E, Grais RF. Routine Amoxicillin for Uncomplicated Severe Acute Malnutrition in Children. N Engl J Med. 2016 Feb 4;374(5):444-53. doi: 10.1056/NEJMoa1507024.
PMID: 26840134DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sheila Isanaka, ScD
Epicentre
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prinicipal Investigator
Study Record Dates
First Submitted
May 26, 2012
First Posted
June 7, 2012
Study Start
October 1, 2012
Primary Completion
March 1, 2014
Study Completion
May 1, 2014
Last Updated
May 21, 2014
Record last verified: 2014-05